• No results found

Policies for biosimilar uptake in Europe : an overview

N/A
N/A
Protected

Academic year: 2019

Share "Policies for biosimilar uptake in Europe : an overview"

Copied!
17
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1. Policies for biosimilars in different countries in Europe (April 2017).
Table 1. (Continued)
Table 1. (Continued)

References

Related documents

Petrescu-Mag Ioan Valentin: Bioflux, Cluj-Napoca (Romania) Petrescu Dacinia Crina: UBB Cluj, Cluj-Napoca (Romania) Sima Rodica Maria: USAMV Cluj, Cluj-Napoca (Romania)

Convergence theory suggests that in the process of global economic development, there is a predicted decrease in inequality between rich and poor countries or between developed

Many of the CASE and CAPE systems surveyed here work towards the ideal of integrating process definition, document construction, and measurement capabilities into a single system

sion, що лунала зі словацького радіо, вже у 1990-ті стала таким самим продуктом популярної культури, як і, наприклад, джинси. Музика, поряд

The discussion and comparisons in Sections 5.1 – 5.4 focused on studying the effects of data form (e.g. tensor components or spectral representation), the ML objective ”loss”

The project supports the mobility of workers across European countries and in some EEA countries (Norway and Iceland), through financial benefits and services addressed to

The EEA Agreement unites The EEA EFTA States Iceland, Liechtenstein and Norway with the 27 EU Member States in an Internal Market governed by the same basic rules.. 450

Near-term earnings, meanwhile, will be impacted by (1) project management and other transition costs related to the transformation initiatives, (2) increased